Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

GlaxoSmithKline is riding high when it comes to the approval of new medicines but US firm Lilly is falling behind. …
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact

